Ketamine Treatment Plans for Chronic Conditions
Observational cohort study (n=500) evaluating real-world home and clinic ketamine treatment plans for people with chronic conditions (pain, depressive and anxiety disorders) and the effect of adjunct therapies.
Details
This observational cohort (cross-sectional elements) will characterise how ketamine is prescribed and delivered off-label across chronic conditions, including routes (IV, IM, SubQ, sublingual and others), dosing patterns, and concurrent treatments.
The study will document adjunct modalities (psychotherapy, music therapy, acutherapy) and examine associations between adjunct use and clinical outcomes for pain, mood and anxiety.
A secondary focus is the relationship between ketamine treatment and suicidal ideation among participants with chronic conditions.